These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Spectrophotometric measurement of proteoglycans in osteoarthritic synovial fluid. Carroll GJ. Ann Rheum Dis; 1987 May; 46(5):375-9. PubMed ID: 3592798 [Abstract] [Full Text] [Related]
3. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M. Ann Rheum Dis; 1997 May; 56(5):299-307. PubMed ID: 9175930 [Abstract] [Full Text] [Related]
4. Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease. Ratcliffe A, Doherty M, Maini RN, Hardingham TE. Ann Rheum Dis; 1988 Oct; 47(10):826-32. PubMed ID: 2461686 [Abstract] [Full Text] [Related]
5. [Quantitative detection of keratan sulfate specific epitopes in synovial fluid in inflammatory and degenerative joint diseases]. Pavelka K, Seibel MJ. Z Rheumatol; 1989 Oct; 48(6):294-300. PubMed ID: 2533769 [Abstract] [Full Text] [Related]
6. Cartilage breakdown in equine osteoarthritis: measurement of keratan sulphate by an ELISA system. Alwan WH, Carter SD, Bennett D, May SA, Edwards GB. Res Vet Sci; 1990 Jul; 49(1):56-60. PubMed ID: 1696390 [Abstract] [Full Text] [Related]
7. Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy. Carroll G, McCappin S, Bell M, Schwarzer A, Breidahl P. Rheumatol Int; 1991 Jul; 11(2):63-8. PubMed ID: 1658913 [Abstract] [Full Text] [Related]
8. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation. Dingle JT, Page Thomas DP, Hazleman B. Int J Tissue React; 1987 Jul; 9(4):349-54. PubMed ID: 3497901 [Abstract] [Full Text] [Related]
9. The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid. Sharif M, Osborne DJ, Meadows K, Woodhouse SM, Colvin EM, Shepstone L, Dieppe PA. Br J Rheumatol; 1996 Oct; 35(10):951-7. PubMed ID: 8883432 [Abstract] [Full Text] [Related]
10. Intrasynovial levels of sulphated glycosaminoglycans and autoantibodies to type II collagen in rheumatoid arthritis: a correlative analysis. Karopoulos C, Rowley MJ, Handley CJ. Rheumatol Int; 1993 Oct; 13(1):15-20. PubMed ID: 8516619 [Abstract] [Full Text] [Related]
11. Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis. Hermann E, Fleischer B, Mayet WJ, Poralla T, Meyer zum Büschenfelde KH. Clin Exp Rheumatol; 1989 Oct; 7(4):411-4. PubMed ID: 2591114 [Abstract] [Full Text] [Related]
12. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O. Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412 [Abstract] [Full Text] [Related]
13. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin. Hasselbacher P. Arthritis Rheum; 1979 Mar 15; 22(3):243-50. PubMed ID: 105740 [Abstract] [Full Text] [Related]
14. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Polgár A, Falus A, Koó E, Ujfalussy I, Seszták M, Szuts I, Konrád K, Hodinka L, Bene E, Mészáros G, Ortutay Z, Farkas E, Paksy A, Buzás EI. Rheumatology (Oxford); 2003 Apr 15; 42(4):522-7. PubMed ID: 12649398 [Abstract] [Full Text] [Related]
15. Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis. Bensouyad A, Hollander AP, Dularay B, Bedwell AE, Cooper RA, Hutton CW, Dieppe PA, Elson CJ. Ann Rheum Dis; 1990 May 15; 49(5):301-7. PubMed ID: 2344209 [Abstract] [Full Text] [Related]
16. The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis. Hørslev-Petersen K, Saxne T, Haar D, Thomsen BS, Bentsen KD, Junker P, Lorenzen I. Rheumatol Int; 1988 May 15; 8(1):1-9. PubMed ID: 3259005 [Abstract] [Full Text] [Related]
17. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Doherty M, Richards N, Hornby J, Powell R. Ann Rheum Dis; 1988 Mar 15; 47(3):190-7. PubMed ID: 2833185 [Abstract] [Full Text] [Related]
19. Synovial fluid chondroitin sulphate epitopes 3B3 and 7D4, and glycosaminoglycan in human knee osteoarthritis after exercise. Bautch JC, Clayton MK, Chu Q, Johnson KA. Ann Rheum Dis; 2000 Nov 15; 59(11):887-91. PubMed ID: 11053067 [Abstract] [Full Text] [Related]
20. Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients. Cha HS, Kim TJ, Kim JY, Lee MH, Jeon CH, Kim J, Bae EK, Ahn KS, Koh EM. Scand J Rheumatol; 2004 Nov 15; 33(3):179-84. PubMed ID: 15228189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]